| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.988 | 0.003 | 0.988 | Analgesic | 0.955 0.004 CID_9847115 0.943 0.004 CID_18595497 | ||
| 0.975 | 0.001 | 0.975 | Analgesic, opioid | 0.89 0.002 CID_9847115 0.837 0.002 CID_18595497 | ||
| 0.97 | 0.002 | 0.981 | Psychostimulant | 0.973 0.002 CID_9847115 0.981 0.001 CID_18595497 | CID_18595497 | |
| 0.881 | 0.002 | 0.881 | Anesthetic general | 0.85 0.002 CID_9847115 0.817 0.002 CID_18595497 | ||
| 0.877 | 0.002 | 0.877 | Opioid agonist | 0.754 0.002 CID_9847115 0.727 0.002 CID_18595497 | ||
| 0.87 | 0.001 | 0.87 | Opioid antagonist | 0.83 0.002 CID_9847115 0.779 0.002 CID_18595497 | ||
| 0.858 | 0.001 | 0.858 | Opioid mu receptor antagonist | 0.804 0.002 CID_9847115 0.743 0.002 CID_18595497 | ||
| 0.857 | 0.001 | 0.857 | Opioid mu receptor agonist | 0.708 0.002 CID_9847115 0.682 0.002 CID_18595497 | ||
| 0.858 | 0.004 | 0.875 | Spasmolytic | 0.846 0.004 CID_9847115 0.875 0.004 CID_18595497 | CID_18595497 | |
| 0.798 | 0.001 | 0.798 | Opioid delta receptor antagonist | 0.73 0.002 CID_9847115 0.692 0.003 CID_18595497 | ||
| 0.778 | 0.001 | 0.778 | Opioid kappa receptor antagonist | 0.691 0.002 CID_9847115 0.651 0.002 CID_18595497 | ||
| 0.77 | 0.002 | 0.77 | Opioid delta receptor agonist | 0.639 0.002 CID_9847115 0.569 0.003 CID_18595497 | ||
| 0.733 | 0.005 | 0.737 | 5 Hydroxytryptamine release stimulant | 0.737 0.005 CID_9847115 0.666 0.009 CID_18595497 | CID_9847115 | |
| 0.725 | 0.003 | 0.725 | Sigma receptor antagonist | 0.19 0.009 CID_9847115 0.22 0.008 CID_18595497 | ||
| 0.698 | 0.003 | 0.698 | Alpha 2a adrenoreceptor antagonist | |||
| 0.659 | 0.001 | 0.659 | Opioid kappa receptor agonist | 0.502 0.002 CID_9847115 0.45 0.002 CID_18595497 | ||
| 0.618 | 0.004 | 0.618 | Alpha 2 adrenoreceptor antagonist | |||
| 0.622 | 0.029 | 0.86 | Transcription factor NF kappa B inhibitor | 0.805 0.012 CID_9847115 0.86 0.009 CID_18595497 | CID_18595497 | |
| 0.553 | 0.005 | 0.553 | Sigma receptor agonist | 0.355 0.029 CID_9847115 0.358 0.029 CID_18595497 | ||
| 0.491 | 0.036 | 0.537 | Immunosuppressant | 0.532 0.025 CID_9847115 0.537 0.024 CID_18595497 | CID_18595497 | |
| 0.486 | 0.093 | 0.745 | Antiinflammatory | 0.674 0.036 CID_9847115 0.745 0.023 CID_18595497 | CID_18595497 | |
| 0.417 | 0.026 | 0.417 | Hypoxia-inducible factor 1 alpha inhibitor | 0.37 0.039 CID_9847115 0.379 0.036 CID_18595497 | ||
| 0.382 | 0.018 | 0.382 | P-glycoprotein inhibitor | 0.259 0.039 CID_9847115 0.286 0.032 CID_18595497 | ||
| 0.356 | 0.009 | 0.356 | Antipruritic | 0.224 0.035 CID_9847115 0.158 0.085 CID_18595497 | ||
| 0.351 | 0.006 | 0.715 | Expectorant | 0.64 0.002 CID_9847115 0.715 0.002 CID_18595497 | CID_18595497 | |
| 0.327 | 0.003 | 0.327 | Toll-Like receptor 4 antagonist | 0.29 0.003 CID_9847115 0.267 0.004 CID_18595497 | ||
| 0.319 | 0.013 | 0.338 | Interleukin 6 antagonist | 0.338 0.011 CID_9847115 0.324 0.012 CID_18595497 | CID_9847115 | |
| 0.302 | 0.014 | 0.302 | Acetylcholine M1 receptor antagonist | |||
| 0.323 | 0.036 | 0.455 | Nitric oxide antagonist | 0.445 0.02 CID_9847115 0.455 0.02 CID_18595497 | CID_18595497 | |
| 0.283 | 0.009 | 0.283 | Toll-Like receptor antagonist | 0.116 0.091 CID_9847115 | ||
| 0.388 | 0.12 | 0.526 | Apoptosis agonist | 0.467 0.085 CID_9847115 0.526 0.067 CID_18595497 | CID_18595497 | |
| 0.277 | 0.017 | 0.277 | Alpha adrenoreceptor antagonist | |||
| 0.288 | 0.052 | 0.288 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.28 | 0.07 | 0.568 | Antioxidant | 0.494 0.021 CID_9847115 0.568 0.014 CID_18595497 | CID_18595497 | |
| 0.214 | 0.009 | 0.214 | Dopamine agonist | 0.09 0.032 CID_9847115 0.082 0.036 CID_18595497 | ||
| 0.23 | 0.025 | 0.23 | Cholinergic antagonist | |||
| 0.202 | 0.008 | 0.202 | Prolactin inhibitor | |||
| 0.217 | 0.027 | 0.217 | Acetylcholine antagonist | |||
| 0.182 | 0.005 | 0.182 | Dopamine D2 agonist | 0.11 0.009 CID_9847115 0.111 0.009 CID_18595497 | ||
| 0.272 | 0.095 | 0.338 | Caspase 3 stimulant | 0.338 0.063 CID_9847115 0.251 0.111 CID_18595497 | CID_9847115 | |
| 0.213 | 0.037 | 0.324 | Protein kinase stimulant | 0.314 0.015 CID_9847115 0.324 0.014 CID_18595497 | CID_18595497 | |
| 0.212 | 0.041 | 0.212 | Cholinergic | |||
| 0.187 | 0.017 | 0.187 | Antineoplastic alkaloid | 0.089 0.056 CID_9847115 0.087 0.058 CID_18595497 | ||
| 0.207 | 0.061 | 0.388 | Hepatoprotectant | 0.388 0.014 CID_9847115 0.373 0.016 CID_18595497 | CID_9847115 | |
| 0.164 | 0.021 | 0.164 | Dopamine D2 antagonist | |||
| 0.257 | 0.122 | 0.257 | Vasodilator, peripheral | 0.25 0.127 CID_9847115 0.207 0.168 CID_18595497 | ||
| 0.157 | 0.024 | 0.157 | Dopamine antagonist | |||
| 0.132 | 0.003 | 0.132 | Prolactin release inhibitor | 0.1 0.004 CID_9847115 0.1 0.004 CID_18595497 | ||
| 0.165 | 0.036 | 0.165 | Acetylcholine muscarinic antagonist | |||
| 0.139 | 0.016 | 0.139 | Dopamine D1 antagonist | |||
| 0.144 | 0.022 | 0.144 | Acetylcholine nicotinic antagonist | |||
| 0.217 | 0.095 | 0.383 | Tumour necrosis factor alpha release inhibitor | 0.372 0.032 CID_9847115 0.383 0.03 CID_18595497 | CID_18595497 | |
| 0.123 | 0.008 | 0.123 | Dopamine D5 antagonist | |||
| 0.148 | 0.036 | 0.148 | Antiadrenergic | |||
| 0.138 | 0.034 | 0.226 | Antineoplastic antibiotic | 0.203 0.021 CID_9847115 0.226 0.017 CID_18595497 | CID_18595497 | |
| 0.155 | 0.052 | 0.155 | Acetylcholinesterase inhibitor | |||
| 0.196 | 0.101 | 0.474 | Free radical scavenger | 0.431 0.024 CID_9847115 0.474 0.019 CID_18595497 | CID_18595497 | |
| 0.097 | 0.006 | 0.097 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.117 | 0.026 | 0.117 | Alpha 2d adrenoreceptor antagonist | |||
| 0.131 | 0.042 | 0.131 | Alpha 2c adrenoreceptor antagonist | |||
| 0.129 | 0.041 | 0.129 | Adrenaline antagonist | |||
| 0.142 | 0.065 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 CID_9847115 0.131 0.115 CID_18595497 | ||
| 0.1 | 0.024 | 0.1 | Neuronal nicotinic receptor antagonist | |||
| 0.195 | 0.123 | 0.473 | Immunostimulant | 0.473 0.033 CID_9847115 0.431 0.041 CID_18595497 | CID_9847115 | |
| 0.2 | 0.136 | 0.2 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.089 | 0.028 | 0.089 | Glycine receptor agonist | 0.083 0.035 CID_9847115 0.066 0.063 CID_18595497 | ||
| 0.115 | 0.054 | 0.115 | Electron transport complex I inhibitor | |||
| 0.183 | 0.123 | 0.363 | Peptidyltransferase inhibitor | 0.363 0.01 CID_9847115 0.341 0.014 CID_18595497 | CID_9847115 | |
| 0.123 | 0.065 | 0.123 | Adenylate cyclase inhibitor | |||
| 0.155 | 0.098 | 0.155 | Lipocortins synthesis antagonist | |||
| 0.098 | 0.042 | 0.119 | ATPase (Vacuolar H+) inhibitor | 0.115 0.023 CID_9847115 0.119 0.02 CID_18595497 | CID_18595497 | |
| 0.125 | 0.072 | 0.125 | MAO inhibitor | |||
| 0.115 | 0.064 | 0.115 | Estrogen antagonist | |||
| 0.104 | 0.057 | 0.104 | Estrogen receptor beta antagonist | |||
| 0.051 | 0.005 | 0.051 | Dopamine D1 agonist | 0.046 0.005 CID_9847115 0.045 0.005 CID_18595497 | ||
| 0.135 | 0.09 | 0.389 | NOS3 expression enhancer | 0.225 0.032 CID_9847115 0.389 0.009 CID_18595497 | CID_18595497 | |
| 0.098 | 0.057 | 0.098 | Breast cancer-resistant protein inhibitor | |||
| 0.138 | 0.1 | 0.182 | Melanin inhibitor | 0.182 0.05 CID_9847115 0.16 0.069 CID_18595497 | CID_9847115 | |
| 0.106 | 0.07 | 0.106 | Cystathionine beta-synthase inhibitor | 0.101 0.075 CID_18595497 | ||
| 0.097 | 0.062 | 0.097 | Creatine kinase inhibitor | |||
| 0.054 | 0.027 | 0.054 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.03 | 0.004 | 0.03 | NMDA receptor phencyclidine site antagonist | |||
| 0.206 | 0.18 | 0.206 | Sodium/bile acid cotransporter inhibitor | |||
| 0.029 | 0.01 | 0.029 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.165 | 0.151 | 0.165 | DNA damaging | |||
| 0.114 | 0.1 | 0.217 | Lipid peroxidase inhibitor | 0.217 0.035 CID_9847115 0.202 0.041 CID_18595497 | CID_9847115 | |
| 0.079 | 0.067 | 0.079 | CC chemokine 5 receptor agonist | |||
| 0.075 | 0.065 | 0.097 | Glycine receptor antagonist | 0.089 0.044 CID_9847115 0.097 0.035 CID_18595497 | CID_18595497 | |
| 0.051 | 0.042 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.053 | 0.046 | 0.053 | Dopamine uptake inhibitor | |||
| 0.088 | 0.083 | 0.088 | Anabolic | |||
| 0.088 | 0.083 | 0.088 | Nav1.1 sodium channel blocker | |||
| 0.033 | 0.031 | 0.033 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.094 | 0.095 | 0.203 | Alkylator | 0.203 0.025 CID_9847115 0.139 0.053 CID_18595497 | CID_9847115 | |
| 0.189 | 0.194 | 0.368 | Apoptosis antagonist | 0.368 0.048 CID_9847115 0.334 0.064 CID_18595497 | CID_9847115 | |
| 0.052 | 0.062 | 0.06 | Lipocortins synthesis agonist | 0.06 0.035 CID_9847115 0.059 0.037 CID_18595497 | CID_9847115 | |
| 0.092 | 0.106 | 0.109 | Microtubule formation inhibitor | 0.109 0.076 CID_9847115 0.104 0.084 CID_18595497 | CID_9847115 | |
| 0.191 | 0.206 | 0.35 | Interleukin 2 agonist | 0.35 0.045 CID_9847115 0.35 0.046 CID_18595497 | CID_18595497 | |
| 0.039 | 0.056 | 0.099 | Protein 50S ribosomal subunit inhibitor | 0.099 0.013 CID_9847115 0.088 0.017 CID_18595497 | CID_9847115 | |
| 0.05 | 0.069 | 0.068 | Nitric oxide donor | 0.067 0.037 CID_9847115 0.068 0.036 CID_18595497 | CID_18595497 | |
| 0.003 | 0.036 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_9847115 | CID_9847115 | |
| 0.025 | 0.067 | 0.065 | Antibiotic Aminoglycoside-like | 0.065 0.007 CID_9847115 0.058 0.009 CID_18595497 | CID_9847115 | |
| 0.045 | 0.096 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 CID_9847115 0.069 0.061 CID_18595497 | CID_9847115 | |
| 0.083 | 0.135 | 0.219 | Cyclooxygenase 3 inhibitor | 0.215 0.014 CID_9847115 0.219 0.013 CID_18595497 | CID_18595497 | |
| 0.131 | 0.188 | 0.254 | Vasodilator | 0.254 0.067 CID_9847115 0.236 0.078 CID_18595497 | CID_9847115 | |
| 0.136 | 0.206 | 0.517 | Hypoglycemic | 0.451 0.02 CID_9847115 0.517 0.014 CID_18595497 | CID_18595497 | |
| 0.105 | 0.179 | 0.157 | Interferon gamma antagonist | 0.157 0.07 CID_9847115 0.157 0.069 CID_18595497 | CID_18595497 | |
| 0.218 | 0.294 | 0.27 | Caspase 9 stimulant | 0.27 0.228 CID_9847115 | CID_9847115 | |
| 0.012 | 0.091 | 0.036 | Protein 30S ribosomal subunit inhibitor | 0.036 0.011 CID_9847115 0.026 0.015 CID_18595497 | CID_9847115 | |
| 0.064 | 0.159 | 0.157 | AMP-activated protein kinase stimulant | 0.157 0.024 CID_9847115 0.121 0.048 CID_18595497 | CID_9847115 | |
| 0.026 | 0.135 | 0.051 | Alpha-mannosidase inhibitor | 0.051 0.041 CID_18595497 | CID_18595497 | |
| 0.131 | 0.248 | 0.246 | DNA synthesis inhibitor | 0.246 0.069 CID_9847115 0.209 0.109 CID_18595497 | CID_9847115 | |
| 0.027 | 0.161 | 0.063 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 CID_9847115 0.063 0.021 CID_18595497 | CID_18595497 | |
| 0.13 | 0.285 | 0.482 | Antithrombotic | 0.482 0.031 CID_9847115 0.436 0.041 CID_18595497 | CID_9847115 | |
| 0.141 | 0.308 | 0.397 | Histamine release inhibitor | 0.397 0.077 CID_9847115 0.301 0.123 CID_18595497 | CID_9847115 | |
| 0.123 | 0.295 | 0.283 | Vasodilator, coronary | 0.273 0.112 CID_9847115 0.283 0.102 CID_18595497 | CID_18595497 | |
| 0.053 | 0.271 | 0.454 | Angiogenesis stimulant | 0.451 0.015 CID_9847115 0.454 0.015 CID_18595497 | CID_18595497 | |
| 0.088 | 0.31 | 0.168 | Cyclic AMP phosphodiesterase inhibitor | 0.168 0.124 CID_18595497 | CID_18595497 | |
| 0.094 | 0.351 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.051 CID_9847115 0.13 0.071 CID_18595497 | CID_9847115 | |
| 0.111 | 0.373 | 0.509 | Antibacterial | 0.509 0.038 CID_9847115 0.499 0.041 CID_18595497 | CID_9847115 | |
| 0.087 | 0.373 | 0.256 | Cholesterol antagonist | 0.256 0.121 CID_9847115 | CID_9847115 | |
| 0.058 | 0.362 | 0.278 | Insulin secretagoues | 0.158 0.066 CID_9847115 0.278 0.015 CID_18595497 | CID_18595497 | |
| 0.025 | 0.343 | 0.142 | Topoisomerase II inhibitor | 0.142 0.053 CID_9847115 0.102 0.084 CID_18595497 | CID_9847115 | |
| 0.018 | 0.339 | 0.082 | Topoisomerase II alpha inhibitor | 0.082 0.052 CID_9847115 | CID_9847115 | |
| 0.02 | 0.355 | 0.109 | Topoisomerase I inhibitor | 0.109 0.063 CID_9847115 0.097 0.072 CID_18595497 | CID_9847115 | |
| 0.009 | 0.368 | 0.228 | Selectin antagonist | 0.228 0.009 CID_9847115 0.228 0.009 CID_18595497 | CID_18595497 | |
| 0.012 | 0.379 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 CID_9847115 0.025 0.023 CID_18595497 | CID_18595497 | |
| 0.038 | 0.461 | 0.228 | Platelet adhesion inhibitor | 0.228 0.057 CID_9847115 0.217 0.062 CID_18595497 | CID_9847115 | |
| 0.03 | 0.455 | 0.142 | Cell wall synthesis inhibitor | 0.142 0.073 CID_9847115 | CID_9847115 | |
| 0.063 | 0.513 | 0.277 | Immunomodulator | 0.254 0.111 CID_9847115 0.277 0.096 CID_18595497 | CID_18595497 | |
| 0.032 | 0.515 | 0.151 | Hemostatic | 0.151 0.067 CID_9847115 0.127 0.101 CID_18595497 | CID_9847115 | |
| 0.033 | 0.516 | 0.088 | Transcription factor NF kappa B stimulant | 0.088 0.054 CID_9847115 0.082 0.065 CID_18595497 | CID_9847115 | |
| 0.071 | 0.562 | 0.573 | Cyclophilin D inhibitor | 0.444 0.069 CID_9847115 0.573 0.032 CID_18595497 | CID_18595497 | |
| 0.023 | 0.551 | 0.168 | Platelet antagonist | 0.168 0.128 CID_18595497 | CID_18595497 | |
| 0.019 | 0.623 | 0.143 | Cell adhesion inhibitor | 0.104 0.082 CID_9847115 0.143 0.051 CID_18595497 | CID_18595497 | |
| 0.01 | 0.752 | 0.147 | Thrombolytic | 0.147 0.084 CID_9847115 0.139 0.09 CID_18595497 | CID_9847115 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |